According to a research report published this morning, Cantor Fitzgerald has initiated Cross Country Healthcare CCRN with a Buy rating and $6 PT.
In the report, Cantor Fitzgerald said, "After years of economic headwinds, Cross Country's fundamentals have improved, and we believe that the stock, which is very near its all-time low, is attractive at current levels. Nurse staffing volume is half of what it was in 2007, and margins are down by two-thirds from their peak, but although demand has already improved, there is substantial potential upside. We expect a big earnings ramp over the next four to six quarters to push the stock higher."
Cross Country Healthcare closed Friday at $4.03.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in